Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Cardiology Plus|August 4, 2023
Understanding COVID-19-related myocarditis: pathophysiology, diagnosis, and treatment strategiesHongyang Shu, Chunxia Zhao, Dao Wen WangJournal of Cellular and Molecular Medicine|July 21, 2022
Pirfenidone alleviates cardiac fibrosis induced by pressure overload via inhibiting TGF-β1/Smad3 signalling pathwayNa Li, Weijian Hang, Hongyang Shu, et al.Frontiers in Cardiovascular Medicine|July 5, 2022
RBM20, a Therapeutic Target to Alleviate Myocardial Stiffness via Titin Isoforms Switching in HFpEFNa Li, Weijian Hang, Hongyang Shu, et al.Frontiers in Pharmacology|February 18, 2021
Trimetazidine in Heart FailureHongyang Shu, Yizhong Peng, Weijian Hang, et al.Biochemical Society Transactions|January 13, 2021
Emerging role of VCP/p97 in cardiovascular diseases: novel insights and therapeutic opportunitiesHongyang Shu, Yizhong Peng, Weijian Hang, et al.Advances in Therapy|November 30, 2021
Clinical Implications of Nicorandil Combined with Trimetazidine in Patients with Coronary Heart Disease: A Real-World Observational StudyLan Shen, Lin Qiu, Jingbo Liu, et al.Cardiovascular Research|November 19, 2020
The role of CD36 in cardiovascular diseaseHongyang Shu, Yizhong Peng, Weijian Hang, et al.The American Journal of Chinese Medicine|September 19, 2022
Salvianolic Acid Ameliorates Pressure Overload-Induced Cardiac Endothelial Dysfunction via Activating HIF1[Formula: see text]/HSF1/CD31 PathwayNa Li, Weijian Hang, Hongyang Shu, et al.Aging and Disease|February 3, 2022
Emerging Roles of Ceramide in Cardiovascular DiseasesHongyang Shu, Yizhong Peng, Weijian Hang, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 27, 2022
Epoxyeicosatrienoic acid: A potential therapeutic target of heart failure with preserved ejection fractionMin Zhang, Hongyang Shu, Chen Chen, et al.Pageof 3